Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.130
-0.160 (-3.73%)
At close: Aug 24, 2026, 4:00 PM EDT
4.170
+0.040 (0.97%)
Pre-market: Aug 25, 2026, 9:06 AM EDT

Ironwood Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
79.13215.4688.5692.15656.2620.13
Cash & Short-Term Investments
79.13215.4688.5692.15656.2620.13
Cash Growth
-14.78%143.29%-3.90%-85.96%5.82%71.04%
Accounts Receivable
112.7346.7581.89129.12115.46114.04
Receivables
112.7346.7581.89129.12115.46114.04
Prepaid Expenses
7.3411.9811.9212.017.728.69
Restricted Cash
----1.251.25
Other Current Assets
-----1.12
Total Current Assets
199.2274.18182.37233.29780.63745.23
Property, Plant & Equipment
11.3612.7515.5218.1720.3122.93
Other Intangible Assets
1.632.042.863.68--
Long-Term Deferred Tax Assets
69.06103.43144.23212.32283.66333.29
Long-Term Deferred Charges
2.42.93.92.4--
Other Long-Term Assets
1.471.62.021.2115.9225.48
Total Assets
285.13396.9350.91471.071,1011,127

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.912.92.137.830.480.94
Accrued Expenses
14.519.182647.2217.7133.29
Current Portion of Long-Term Debt
-199.68-199.56-116.86
Current Portion of Leases
3.293.253.193.133.073.13
Current Income Taxes Payable
4.280.930.521.240.66-
Current Unearned Revenue
1.251.112.032.62--
Other Current Liabilities
8.6215.184.9814.53.617.49
Total Current Liabilities
32.85242.2238.85276.125.53161.7
Long-Term Debt
385385583.99498.31396.25337.33
Long-Term Leases
8.589.8712.314.5416.618.48
Long-Term Unearned Revenue
4.45.3----
Other Long-Term Liabilities
16.1416.3517.1128.429.773.5
Total Liabilities
446.97658.74652.24817.37448.14521.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.170.160.160.160.150.16
Additional Paid-In Capital
1,4201,4131,3951,3551,3491,543
Retained Earnings
-1,582-1,674-1,698-1,699-696.38-937.61
Comprehensive Income & Other
-0.32-1.060.92-3.03--
Shareholders' Equity
-161.84-261.84-301.34-346.3652.38605.91
Total Liabilities & Equity
285.13396.9350.91471.071,1011,127

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
396.87597.8599.48715.54415.92475.8
Net Cash (Debt)
-317.74-382.35-510.92-623.38240.29144.33
Net Cash Growth
----66.49%-
Net Cash Per Share
-1.92-2.35-3.19-4.011.290.88
Filing Date Shares Outstanding
165.24163.06161.81156.53154.16159.22
Total Common Shares Outstanding
165.24163.06160.21156.35154.03162.04
Working Capital
166.3531.96143.52-42.81755.1583.53
Book Value Per Share
-0.98-1.61-1.88-2.214.243.74
Tangible Book Value
-163.48-263.88-304.2-349.98652.38605.91
Tangible Book Value Per Share
-0.99-1.62-1.90-2.244.243.74
Machinery
-3.763.895.424.234.13
Leasehold Improvements
-7.447.417.417.417.41
SEC Filings: 10-K · 10-Q